Volume 3: Issue 5-6
pp135-185
About the CoverThe cover for this issue of Oncoscience features Figure 5 ("Familial adenomatous patients with desmoid tumours show increased expression of miR-34a in serum and high levels in tumours") from Walton et al. |
News
Persistent infections, immune-senescence and Alzheimer's disease
https://doi.org/10.18632/oncoscience.309
Federico Licastro, Elisa Porcellini
p 135-142
Editorials
XPO1, therapeutic...and prognostic target in sarcomas
https://doi.org/10.18632/oncoscience.304
François Bertucci, Pascal Finetti, Daniel Birnbaum
p 143-144
The role of BRCA1-IRIS in ovarian cancer formation, drug resistance and progression
https://doi.org/10.18632/oncoscience.308
Wael M. ElShamy
p 145-146
Ibrutinib repurposing: from B-cell malignancies to solid tumors
https://doi.org/10.18632/oncoscience.310
Daniel Massó-Vallés, Toni Jauset, Laura Soucek
p 147-148
Reviews
Hidden association of Cowden syndrome, PTEN mutation and meningioma frequency
https://doi.org/10.18632/oncoscience.305
Eduard Yakubov, Ali Ghoochani, Rolf Buslei, Michael Buchfelder, Ilker Y. Eyüpoglu, Nicolai Savaskan
p 149-155
Abstract | PDF | Full Text | Supplementary Material | How to Cite
Case Reports
Durable response of glioblastoma to adjuvant therapy consisting of temozolomide and a weekly dose of AMD3100 (plerixafor), a CXCR4 inhibitor, together with lapatinib, metformin and niacinamide
https://doi.org/10.18632/oncoscience.311
Adan Rios, Sigmund H. Hsu, Angel Blanco, Jamie Buryanek, Arthur L.Day, Mary F. McGuire, Robert E. Brown
p 156-163
Abstract | PDF | Full Text | How to Cite
Research Papers
Presence of both alterations in FGFR/FGF and PI3K/AKT/mTOR confer improved outcomes for patients with metastatic breast cancer treated with PI3K/AKT/mTOR inhibitors
https://doi.org/10.18632/oncoscience.307
Jennifer J. Wheler, Johnique T. Atkins, Filip Janku, Stacy L. Moulder, Philip J. Stephens, Roman Yelensky, Vicente Valero, Vincent Miller, Razelle Kurzrock, Funda Meric-Bernstam
p 164-172
Abstract | PDF | Full Text | How to Cite
Familial adenomatous patients with desmoid tumours show increased expression of miR-34a in serum and high levels in tumours
https://doi.org/10.18632/oncoscience.312
Sarah-Jane Walton, Amy Lewis, Rosemary Jeffery, Hannah Thompson, Roger Feakins, Eleni Giannoulatou, Christopher Yau, James O. Lindsay, Susan K. Clark, Andrew Silver
p 173-185
Abstract | PDF | Full Text | Supplementary Table | Supplementary Materials | How to Cite